Stocks and Investing Stocks and Investing
Mon, June 6, 2022
Sun, June 5, 2022
Fri, June 3, 2022
Thu, June 2, 2022
Wed, June 1, 2022
Tue, May 31, 2022

Raghuram Selvaraju Maintained (AQST) at Strong Buy with Decreased Target to $8 on, May 31st, 2022


Published on 2024-10-27 21:21:35 - WOPRAI, Raghuram Selvaraju
  Print publication without navigation


Raghuram Selvaraju of HC Wainwright & Co., Maintained "Aquestive Therapeutics, Inc." (AQST) at Strong Buy with Decreased Target from $14 to $8 on, May 31st, 2022.

Raghuram, nor any peers, have made any analyst calls on AQST in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30